glp-1 therapy d'iberville Therapeutic phlebotomy for TRT in Slidell GLP-1 Microdosing, Brain Health &

One of those dual agonists, tirzepatide (Mounjaro/Zepbound, Eli Lilly), was associated with a mean 14.7% weight loss for adults with overweight or obesity and type 2 diabetes in the SURMOUNT-2 trial compared with a 3.2% weight loss with placebo

comparing a 7 versus 28day dosing interval in Figure 2A), though clinical validation is especially warranted for this prediction

so i did

As a drug, they mimic the natural hormone (GLP-1) that acts to control appetite and food intake by binding to receptors in the brain and pancreas and causing activation of several related pathways

Unfortunately, that's not how it works

Glucagon-like peptide-1 (GLP-1) receptor agonists: Exploring their impact on diabetes, obesity, and cardiovascular health through a comprehensive literature review